Revolution Biomanufacturing

Celebrating Excellence at Advanced Therapies Week in Dallas! ?? Last night, we had the incredible honor of witnessing Molly McGlaughlin receive the "Women in Advanced Therapies Award" at Advanced Therapies Week in Dallas! This prestigious recognition highlights her outstanding contributions, and hard work, while pushing the boundaries of innovation. Molly's leadership continues to inspire, making a meaningful impact on the industry and beyond. Well done, Molly! ?? Kelvin S. L. Chan, Ph.D., Atsuko Sakurai-Sangria, Sara Townsend-Meave, Meltem ?ORBACIO?LU PALA, Manika Bhondeley, PhD, Changyuan Lu, Wenhui Gao, Josh Seim, Andy Lewin,Sam Conlon, Michael Kimble, MBA

So proud of my team at Kudo Biotechnology and our collaborators at LineaRx, Inc. Applied DNA Sciences in publishing this data-packed white paper on a synthetic DNA platform for mRNA production in 2-6 weeks instead of months, while also minimizing dsRNA and maintaining scalability. Hope you enjoy the read! #mRNA #syntheticDNA #dsRNA #GMP

Kudo Biotechnology?and?LineaRx?present: ?WHITE PAPER – "Fast-tracking mRNA Medicines: A synthetic DNA platform to optimize mRNA production" We introduce a streamlined, flexible process for mRNA therapeutic production that eliminates traditional pDNA steps. Using cell-free enzymatic production from our partner LineaRx on the Kudo Bio platform, we enable faster, cost-effective, and scalable cGMP manufacturing of high-quality mRNA. The white paper also highlights LineaRx’s proprietary RNA polymerase, which, when combined with the linear dsDNA template, minimizes dsRNA impurities for an added advantage. Download the white paper here https://lnkd.in/g4rSvWdK

Excited to share that Molly McGlaughlin, CEO of Kudo Biotechnology, is the January "Spotlight" on Mantell Associates'! A true leader in the biotech industry, Molly continues to inspire with her vision and dedication to advancing personalized medicine.?Kelvin S. L. Chan, Ph.D., Andy Lewin, Atsuko Sakurai-Sangria, Kathleen Brackett, Sara Townsend-Meave, Meltem ?ORBACIO?LU PALA, Changyuan Lu, Manika Bhondeley, PhD, Josh Seim, Sam Conlon #mRNA #pDNA #LNP #CDMO

We’re proud to share that Molly McGlaughlin, CEO of Kudo Biotechnology, is attending Advanced Therapies Week and has been nominated for TWO prestigious awards! ?? Molly’s incredible journey from Colonel in the US Army to leading a cutting-edge CDMO highlights her dedication to innovation, collaboration, and advancing the biotech industry. If you’re at #ATW, connect with Molly to learn more about us. Let’s celebrate innovation, leadership, and the power of collaboration! Kelvin S. L. Chan, Ph.D., Kathleen Brackett, Josh Seim, Atsuko Sakurai-Sangria, Sara Townsend-Meave, Manika Bhondeley, PhD, Meltem ?ORBACIO?LU PALA, Michael Kimble, MBA, Changyuan Lu, Sam Conlon #mRNA #pDNA #LNP #CDMO

?? Kudo Biotechnology is Heading to JPM Week in San Francisco! ?? We’re excited to announce that our CEO, Molly McGlaughlin, will be attending JPM Week in San Francisco! She will be available for meetings throughout the week (Monday to Thursday). This is a fantastic opportunity to connect and collaborate. If you’d like to schedule a time to meet, we’d love to hear from you! Please send your request to [email protected]. Looking forward to seeing you there! Molly McGlaughlin, Kelvin S. L. Chan, Ph.D., Atsuko Sakurai-Sangria, Changyuan Lu, Sara Townsend-Meave, Manika Bhondeley, PhD, Meltem ?ORBACIO?LU PALA, Josh Seim, Wenhui Gao, Kathleen Brackett #mRNA #pDNA #LNP #CDMO

Instead of traditional trial-and-error methods, AI was used to predict important properties of ionizable lipids, which are critical for LNP performance. The research tested nearly 20 million lipid compounds, identifying several new molecules that outperformed existing ones in delivering mRNA in mice, showing how AI can streamline and enhance the design of these materials.

???? Happy New Year from all of us at Kudo Biotechnology! ???? As we kick off 2025, we’re feeling grateful and excited about what’s ahead. 2024 was a big year for us—growing our services and teaming up with amazing partners. We couldn’t have done it without our incredible team and the support of our clients and friends in the biotech community. Let’s make 2025 even better—together! Wishing you a happy, healthy, and inspiring New Year! ??Molly McGlaughlin, Kelvin S. L. Chan, Ph.D., Atsuko Sakurai-Sangria, Manika Bhondeley, PhD, Sara Townsend-Meave, Meltem ?ORBACIO?LU PALA, Josh Seim, Kathleen Brackett, Changyuan Lu, Sam Conlon, Michael Kimble, MBA, Andy Lewin #mRNA #pDNA #LNP #CDMO

??? Happy Holidays from Kudo Biotechnology! ??? Wishing you and your loved ones a joyous holiday season filled with warmth, happiness, and plenty of cheer. Here’s to a successful and inspiring 2025! Molly McGlaughlin, Kelvin S. L. Chan, Ph.D., Atsuko Sakurai-Sangria, Meltem ?ORBACIO?LU PALA, Sara Townsend-Meave, Michael Kimble, MBA, Changyuan Lu, Sam Conlon, Josh Seim, Kathleen Brackett, Manika Bhondeley, PhD, Wenhui Gao #mRNA #pDNA #LNP #HappyHolidays

This week, our Needham team came together for an afternoon potluck filled with amazing food, laughter, and the spirit of the season. It was a wonderful reminder of the joy and connection that comes from sharing a meal and celebrating as a team. Grateful for this incredible group and the energy they bring every day! Molly McGlaughlin, Kelvin S. L. Chan, Ph.D., Michael Kimble, MBA, Atsuko Sakurai-Sangria, Sara Townsend-Meave, Manika Bhondeley, PhD, Changyuan Lu, Meltem ?ORBACIO?LU PALA, Josh Seim, Kathleen Brackett, Sam Conlon #pDNA #mRNA #LNP #CDMO